2.4.0.8100260 - Disclosure - Revenue Accounted for 10% or More of Total Revenues (Detail)truefalsefalse1false falsefalseC_0001269021_us-gaapMajorCustomersAxis_ptlaNovartisMember_20130401_20130630http://www.sec.gov/CIK0001269021duration2013-04-01T00:00:002013-06-30T00:00:00U_pureStandardhttp://www.xbrl.org/2003/instancepure02false falsefalseC_0001269021_us-gaapMajorCustomersAxis_ptlaNovartisMember_20120401_20120630http://www.sec.gov/CIK0001269021duration2012-04-01T00:00:002012-06-30T00:00:00U_pureStandardhttp://www.xbrl.org/2003/instancepure03false falsefalseC_0001269021_us-gaapMajorCustomersAxis_ptlaNovartisMember_20130101_20130630http://www.sec.gov/CIK0001269021duration2013-01-01T00:00:002013-06-30T00:00:00U_pureStandardhttp://www.xbrl.org/2003/instancepure04false falsefalseC_0001269021_us-gaapMajorCustomersAxis_ptlaNovartisMember_20120101_20120630http://www.sec.gov/CIK0001269021duration2012-01-01T00:00:002012-06-30T00:00:00U_pureStandardhttp://www.xbrl.org/2003/instancepure01false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse1false truefalseC_0001269021_us-gaapMajorCustomersAxis_ptlaNovartisMember_20130401_20130630http://www.sec.gov/CIK0001269021duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseNovartis AG ("Novartis")us-gaap_MajorCustomersAxisxbrldihttp://xbrl.org/2006/xbrldiptla_NovartisMemberus-gaap_MajorCustomersAxisexplicitMemberU_pureStandardhttp://www.xbrl.org/2003/instancepure0nanafalse0Novartis AG ("Novartis")2true 3us-gaap_ConcentrationRiskLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Concentration Risk [Line Items]3false 4us-gaap_EntityWideRevenueMajorCustomerPercentageus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsetruefalse00  falsefalsefalse2truetruefalse1.001.00falsefalsefalse3falsetruefalse00  falsefalsefalse4truetruefalse1.001.00falsefalsefalsenum:percentItemTypepurePercentage of revenue generated from a single external customer that accounts for 10 percent or more of an entity's revenues.No definition available.false0Percentage of major customers revenue accounted for 10% or more of total revenues4false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5false truefalseC_0001269021_us-gaapMajorCustomersAxis_ptlaBristolMyersSquibbCompanyAndPfizerIncMember_20130401_20130630http://www.sec.gov/CIK0001269021duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseBristol-Myers Squibb Company ("BMS") and Pfizer Inc. ("Pfizer")us-gaap_MajorCustomersAxisxbrldihttp://xbrl.org/2006/xbrldiptla_BristolMyersSquibbCompanyAndPfizerIncMemberus-gaap_MajorCustomersAxisexplicitMemberU_pureStandardhttp://www.xbrl.org/2003/instancepure0nanafalse0Bristol-Myers Squibb Company ("BMS") and Pfizer Inc. ("Pfizer")5true 3us-gaap_ConcentrationRiskLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Concentration Risk [Line Items]6false 4us-gaap_EntityWideRevenueMajorCustomerPercentageus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truetruefalse0.430.43falsefalsefalse2falsetruefalse00  falsefalsefalse3truetruefalse0.540.54falsefalsefalse4falsetruefalse00  falsefalsefalsenum:percentItemTypepurePercentage of revenue generated from a single external customer that accounts for 10 percent or more of an entity's revenues.No definition available.false0Percentage of major customers revenue accounted for 10% or more of total revenues7false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse9false truefalseC_0001269021_us-gaapMajorCustomersAxis_ptlaBayerPharmaAgAndJanssenPharmaceuticalsIncrMember_20130401_20130630http://www.sec.gov/CIK0001269021duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseBayer Pharma, AG ('Bayer") and Janssen Pharmaceuticals, Inc. ("Janssen")us-gaap_MajorCustomersAxisxbrldihttp://xbrl.org/2006/xbrldiptla_BayerPharmaAgAndJanssenPharmaceuticalsIncrMemberus-gaap_MajorCustomersAxisexplicitMemberU_pureStandardhttp://www.xbrl.org/2003/instancepure0nanafalse0Bayer Pharma, AG ('Bayer") and Janssen Pharmaceuticals, Inc. ("Janssen")8true 3us-gaap_ConcentrationRiskLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Concentration Risk [Line Items]9false 4us-gaap_EntityWideRevenueMajorCustomerPercentageus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truetruefalse0.510.51falsefalsefalse2falsetruefalse00  falsefalsefalse3truetruefalse0.430.43falsefalsefalse4falsetruefalse00  falsefalsefalsenum:percentItemTypepurePercentage of revenue generated from a single external customer that accounts for 10 percent or more of an entity's revenues.No definition available.false0Percentage of major customers revenue accounted for 10% or more of total revenuesfalseRevenue Accounted for 10% or More of Total Revenues (Detail)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.portola.com/20130630/taxonomy/role/DisclosureRevenueAccountedFor10OrMoreOfTotalRevenuesDetail49